Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: The three-year results of the PEPCAD II ISR study

EuroIntervention

Volumn 11, Issue 8, 2015, Pages 926-934

  Unverdorben, Martin ^a   Vallbracht, Christian ^b   Cremers, Bodo ^c   Heuer, Hubertus ^d   Hengstenberg, Christian ^e   Maikowski, Christian ^f   Werner, Gerald S ^g   Antoni, Diethmar ^h   Kleber, Franz X ⁱ   Bocksch, Wolfgang ^j   Leschke, Matthias ^k   Ackermann, Hanns ^l   Boxberger, Michael ^m   Speck, Ulrich ^j   Degenhardt, Ralf ^a   Scheller, Bruno ^c  

^a Inst für Klinische Forschung   (Germany)

^b Herz und Kreislaufzentrum   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d ST JOHANNES HOSPITAL   (Germany)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f KERCKHOFF HEART CENTER   (Germany)

^g KLINIKUM DARMSTADT   (Germany)

^h KLINIKUM BOGENHAUSEN   (Germany)

ⁱ UNFALLKRANKENHAUS BERLIN   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k KLINIKUM ESSLINGEN   (Germany)

^l GOETHE UNIVERSITY   (Germany)

^m B Braun Melsungen AG   (Germany)

more..

Author keywords

Drug coated balloon; Long tern follow up; Paclitaxel

Indexed keywords

PACLITAXEL; ANTITHROMBOCYTIC AGENT; BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT; METAL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; BARE METAL STENT; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; CORONARY IN STENT RESTENOSIS; DRUG ELUTING STENT; FEMALE; HEART DISEASE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PACLITAXEL COATED BALLOON CATHETER; PACLITAXEL COATED CATHETER; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DEVICES; DISEASE FREE SURVIVAL; GERMANY; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; RETREATMENT; STENT; TIME FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; GERMANY; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIER ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; RETREATMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84954203135     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY14M08_12     Document Type: Article

References (30)

1. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol. 2010;99:165-74.
2. Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention. 2011;7:K61-5.
3. Unverdorben M, Kleber FX, Heuer H, Figulla H, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Scheller B. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months? EuroIntervention. 2013.9:620-8.
4. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355:2113-24.
5. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119:2986-94.
6. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, Van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and pacli-taxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-78.
7. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-30.
8. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:989-97.
9. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L; SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009-19.
10. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol. 2008;97:773-81.
11. Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Speck U, Bohm M, Cremers B. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 2012;5:323-30.
12. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810-4.
13. Cremers B, Speck U, Kaufels N, Mahnkopf D, Kuhler M, Bohm M, Scheller B. Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost. 2009;101:201-6.
14. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51.
15. Iofina E, Langenberg R, Blindt R, Kuhl H, Kelm M, Hoffmann R. Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions. Am J Cardiol. 2006;98:1022-7.
16. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schühlen H, Schmitt C, Dirschinger J, Schömig A; ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293:165-71.
17. Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation. 2001;104:600-5.
18. Iofina E, Radke P, Schubert D, Langenberg R, Blindt R, Hanrath P, Hoffmann R. Three-year follow-up after intracoronary beta-radiation therapy for in-stent restenosis. Catheter Cardiovasc Interv. 2006;67:600-6.
19. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202.
20. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701-5.
21. Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D'Ascenzo F, Kimura T, Briguori C, Sabate M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;379:1393-402.
22. Dommke C, Haase KK, Suselbeck T, Streitner I, Haghi D, Metz J, Borggrefe M, Herdeg C. Local paclitaxel delivery after coronary stenting in an experimental animal model. Thromb Haemost. 2007;98:674-80.
23. Herdeg C, Gohring-Frischholz K, Haase KK, Geisler T, Zurn C, Hartmann U, Wohrle J, Nusser T, Dippon J, May AE, Gawaz M. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Circ Cardiovasc Interv. 2009;2:294-301.
24. Axel DI, Kunert W, Göggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Köveker G, Karsch KR. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636-45.
25. Herdeg C, Oberhoff M, Baumbach A, Blattner A, Kuttner A, Schroder S, Haase KK, Karsch KR. Visualization and comparison of drug effects after local paclitaxel delivery with different catheter types. Basic Res Cardiol. 1999;94:454-63.
26. Park KW, Kim CH, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS. Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents. Am Heart J. 2010;159:446-53.
27. Yang TH, Kim DI, Jin HY, Cho YW, Chung SR, Kim DK, Kim YB, Jang JS, Kim U, Seol SH, Kim DK, Kim DS. "Angiographic late catch-up" phenomenon after sirolimus-eluting stent implanta tion. Int J Cardiol. 2012;160:48-52.
28. Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW, Sousa AG. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation. 2005;111:2326-9.
29. Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol. 2012;59:2051-7.
30. Byrne RA, Joner M, Tada T, Kastrati A. Restenosis in bare metal and drug-eluting stents: distinct mechanistic insights from histopathology and optical intravascular imaging. Minerva Cardioangiol. 2012;60:473-89.